This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Should You Add Air Products (APD) Stock to Your Portfolio
by Zacks Equity Research
Air Products (APD) benefits from its investments in high-return industrial gas projects, project wins and productivity initiatives.
Cabot (CBT) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Cabot (CBT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Cabot (CBT) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
CBT or AIQUY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
Is Cabot (CBT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Hawkins (HWKN) Up 51% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Hawkins (HWKN) benefits from the robust Water Treatment segment, strategic acquisitions and a prudent pricing strategy.
CBT or AIQUY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
Is Cabot (CBT) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Cabot (CBT) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cabot (CBT) Up 6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
Why Cabot (CBT) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
Here's Why Cabot (CBT) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cabot (CBT) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
Should Value Investors Buy Cabot (CBT) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cabot (CBT) Unveils REPLASBLAK Masterbatch Product Family
by Zacks Equity Research
Cabot's (CBT) newly released EVOLVE Sustainable Solutions technology platform is intended to create products with sustainable content and dependable performance at an industrial scale.
Cabot's (CBT) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
The decline in sales of Cabot's (CBT) Reinforcement Materials unit is due to reduced sales in the Americas and EMEA in the fiscal fourth quarter.
Cabot (CBT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Cabot (CBT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Chemours (CC) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of -16.88% and 3.63%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
CBT vs. AIQUY: Which Stock Is the Better Value Option?
by Zacks Equity Research
CBT vs. AIQUY: Which Stock Is the Better Value Option?
Stepan Co. (SCL) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of -15.79% and 6.88%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Boosts Circularity & Traceability With ISCC PLUS
by Zacks Equity Research
Cabot's (CBT) ISCC PLUS certified facilities adhere to ISCC PLUS requirements by leveraging circular value chains and certified feedstocks in the product manufacturing process.
Why Is Cabot (CBT) Up 2.2% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot (CBT) Joins US Energy Department's Better Plants Program
by Zacks Equity Research
Cabot (CBT) believes that this engagement with the DOE will help the company boost its energy efficiency performance.
Cabot (CBT) Q3 Earnings & Revenues Miss Estimates, Fall Y/Y
by Zacks Equity Research
Cabot (CBT) lags third-quarter earnings and revenue estimates due to low volumes in its segments.